Related Articles
DBV Technologies Reports Second Quarter 2022 Financial Results – GlobeNewswire
August 01, 2022 16:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A. Montrouge, FRANCE Montrouge, France, August 1, 2022DBV Technologies Reports Second Quarter 2022…
DBV Technologies Reports Third Quarter Financial Results and Business Update – GlobeNewswire
November 03, 2022 16:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A. Montrouge, FRANCE Montrouge, France, November 3, 2022DBV Technologies Reports Third Quarter Financial…
DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers – GlobeNewswire
June 07, 2022 16:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A. Montrouge, FRANCE Montrouge, France, June 7, 2022DBV Technologies Announces Positive Topline Results…
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial – Yahoo Finance
Montrouge, France, December 23, 2022 DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial DBV expects to initiate patient screening…
DBV Technologies to Highlight New Clinical Data at ACAAI 2022 – GlobeNewswire
November 09, 2022 01:30 ET | Source: DBV Technologies S.A. DBV Technologies S.A. Montrouge, FRANCE Montrouge, France, November 9, 2022 DBV Technologies to Highlight New…